Drugs Made In America Acquisition Corp. - 8-K Filing

Drugs Made In America Acquisition Corp. amends merger agreement with Power Analytics Global Corp. to include a $1.71B standalone valuation contingency. (Items: 1.01 Entry into a Material Definitive Agreement, 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR · October 21, 2026, 21:27 UTC

Tickers: $DMAAU

Read the full article at SEC EDGAR

Part of the story Drugs Made In America Acquisition Corp. - 8-K Filing (3 articles)

More Regulatory news

TRANSCONTINENTAL REALTY INVESTORS INC - 10-Q Filing SEC EDGAR · November 12, 2026, 17:33 UTC
AMERICAN REALTY INVESTORS INC - 10-Q Filing SEC EDGAR · November 12, 2026, 17:31 UTC
Home Federal Bancorp, Inc. of Louisiana - 10-Q Filing SEC EDGAR · November 12, 2026, 17:12 UTC
LiveRamp Holdings, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 16:52 UTC
Presurance Holdings, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 16:43 UTC
EXPEDITORS INTERNATIONAL OF WASHINGTON INC - 8-K Filing SEC EDGAR · November 12, 2026, 16:42 UTC
AUDIOEYE INC - 10-Q Filing SEC EDGAR · October 26, 2026, 21:11 UTC
ROCKWELL AUTOMATION, INC - 10-K Filing SEC EDGAR · November 12, 2026, 16:35 UTC
United KSK Corp - 10-Q Filing SEC EDGAR · November 12, 2026, 16:29 UTC
AMERICAN SHARED HOSPITAL SERVICES - 8-K Filing SEC EDGAR · November 12, 2026, 16:27 UTC